BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 2604740)

  • 1. In vivo conversion of gamma-aminobutyric acid and 1,4-butanediol to gamma-hydroxybutyric acid in rat brain. Studies using stable isotopes.
    Snead OC; Furner R; Liu CC
    Biochem Pharmacol; 1989 Dec; 38(24):4375-80. PubMed ID: 2604740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the relation of gamma-hydroxybutyric acid (GHB) to gamma-aminobutyric acid (GABA). Evidence that GABA is not the sole source for GHB in rat brain.
    Snead OC; Liu CC; Bearden LJ
    Biochem Pharmacol; 1982 Dec; 31(23):3917-23. PubMed ID: 7159469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,4 Butanediol, gamma-hydroxybutyric acid and ethanol: relationships and interactions.
    Poldrugo F; Snead OC
    Neuropharmacology; 1984 Jan; 23(1):109-113. PubMed ID: 6717752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effects of GHB precursors GBL and 1,4-BD following i.c.v. administration in rats.
    Carter LP; Koek W; France CP
    Eur J Neurosci; 2006 Nov; 24(9):2595-600. PubMed ID: 17100847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous gamma-hydroxybutyrate in rat brain areas: postmortem changes and effects of drugs interfering with gamma-aminobutyric acid metabolism.
    Eli M; Cattabeni F
    J Neurochem; 1983 Aug; 41(2):524-30. PubMed ID: 6875551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drosophila metabolize 1,4-butanediol into gamma-hydroxybutyric acid in vivo.
    Satta R; Dimitrijevic N; Manev H
    Eur J Pharmacol; 2003 Jul; 473(2-3):149-52. PubMed ID: 12892832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central effects of 1,4-butanediol are mediated by GABA(B) receptors via its conversion into gamma-hydroxybutyric acid.
    Carai MA; Colombo G; Reali R; Serra S; Mocci I; Castelli MP; Cignarella G; Gessa GL
    Eur J Pharmacol; 2002 Apr; 441(3):157-63. PubMed ID: 12063087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma-Hydroxybutyrate (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) reduce the volume of cerebral infarction in rodent transient middle cerebral artery occlusion.
    Sadasivan S; Maher TJ; Quang LS
    Ann N Y Acad Sci; 2006 Aug; 1074():537-44. PubMed ID: 17105951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. gamma-Hydroxybutyric acid in subcellular fractions of rat brain.
    Snead OC
    J Neurochem; 1987 Jan; 48(1):196-201. PubMed ID: 3794700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GC/MS profiling of gamma-hydroxybutyrate and precursors in various animal tissues using automatic solid-phase extraction. Preliminary investigations of its potential interest in postmortem interval determination.
    Richard D; Ling B; Authier N; Faict TW; Eschalier A; Coudoré F
    Anal Chem; 2005 Mar; 77(5):1354-60. PubMed ID: 15732918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion of gamma-hydroxybutyrate to gamma-aminobutyrate in vitro.
    Vayer P; Mandel P; Maitre M
    J Neurochem; 1985 Sep; 45(3):810-4. PubMed ID: 2863327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation for the withdrawal syndrome from gamma-hydroxybutyric acid (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) in different rat lines.
    Quang LS; Colombo G; Lobina C; Maccioni P; Orru A; Gessa GL; Maher TJ; Carai MA
    Ann N Y Acad Sci; 2006 Aug; 1074():545-58. PubMed ID: 17105952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental absence seizures: potential role of gamma-hydroxybutyric acid and GABAB receptors.
    Bernasconi R; Lauber J; Marescaux C; Vergnes M; Martin P; Rubio V; Leonhardt T; Reymann N; Bittiger H
    J Neural Transm Suppl; 1992; 35():155-77. PubMed ID: 1324978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a role of high Km aldehyde reductase in the degradation of endogenous gamma-hydroxybutyrate from rat brain.
    Vayer P; Schmitt M; Bourguignon JJ; Mandel P; Maitre M
    FEBS Lett; 1985 Oct; 190(1):55-60. PubMed ID: 3899725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gamma-hydroxybutyrate model of absence seizures: correlation of regional brain levels of gamma-hydroxybutyric acid and gamma-butyrolactone with spike wave discharges.
    Snead OC
    Neuropharmacology; 1991 Feb; 30(2):161-7. PubMed ID: 2030821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withdrawal syndrome from gamma-hydroxybutyric acid (GHB) and 1,4-butanediol (1,4-BD) in Sardinian alcohol-preferring rats.
    Carai MA; Quang LS; Atzeri S; Lobina C; Maccioni P; Orrù A; Gessa GL; Maher TJ; Colombo G
    Brain Res Brain Res Protoc; 2005 Jul; 15(2):75-8. PubMed ID: 15886053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of a convenient extraction procedure to analyze gamma-hydroxybutyric acid in fatalities involving gamma-hydroxybutyric acid, gamma-butyrolactone, and 1,4-butanediol.
    Duer WC; Byers KL; Martin JV
    J Anal Toxicol; 2001 Oct; 25(7):576-82. PubMed ID: 11599603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol.
    Schep LJ; Knudsen K; Slaughter RJ; Vale JA; Mégarbane B
    Clin Toxicol (Phila); 2012 Jul; 50(6):458-70. PubMed ID: 22746383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons.
    Goodwin AK; Brown PR; Jansen EE; Jakobs C; Gibson KM; Weerts EM
    Psychopharmacology (Berl); 2009 Jun; 204(3):465-76. PubMed ID: 19198808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use.
    Corkery JM; Loi B; Claridge H; Goodair C; Corazza O; Elliott S; Schifano F
    Neurosci Biobehav Rev; 2015 Jun; 53():52-78. PubMed ID: 25843781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.